Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT05799521
PHASE2

A Nasal Treatment for COVID-19

Sponsor: Indiana University

View on ClinicalTrials.gov

Summary

The goal of this study is to test an investigational new inhaled medication called Optate.

Official title: A Novel Nasal Treatment for COVID-19

Key Details

Gender

All

Age Range

18 Years - 60 Years

Study Type

INTERVENTIONAL

Enrollment

40

Start Date

2023-06-27

Completion Date

2026-03-30

Last Updated

2025-12-22

Healthy Volunteers

Yes

Conditions

Interventions

DRUG

Optate

Alkaline Buffer

DRUG

Placebo

Normal Saline

Locations (1)

Riley Hospital for Children

Indianapolis, Indiana, United States